Geode Capital Management LLC Cuts Stock Holdings in SWK Holdings Co. (NASDAQ:SWKH)

Geode Capital Management LLC cut its stake in shares of SWK Holdings Co. (NASDAQ:SWKH) by 9.0% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 75,306 shares of the company’s stock after selling 7,465 shares during the quarter. Geode Capital Management LLC’s holdings in SWK were worth $1,302,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Barclays PLC boosted its holdings in SWK by 185.0% in the third quarter. Barclays PLC now owns 4,461 shares of the company’s stock valued at $77,000 after acquiring an additional 2,896 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in SWK during the second quarter worth about $172,000. Dimensional Fund Advisors LP raised its holdings in shares of SWK by 85.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company’s stock worth $511,000 after purchasing an additional 13,892 shares during the period. SkyView Investment Advisors LLC lifted its stake in shares of SWK by 7.7% in the 2nd quarter. SkyView Investment Advisors LLC now owns 31,165 shares of the company’s stock valued at $529,000 after purchasing an additional 2,234 shares in the last quarter. Finally, Victory Capital Management Inc. purchased a new stake in shares of SWK during the 3rd quarter worth about $589,000. 99.27% of the stock is currently owned by institutional investors and hedge funds.

SWK Stock Down 0.2 %

SWKH opened at $16.12 on Friday. The company has a market cap of $197.20 million, a PE ratio of 17.33 and a beta of 0.36. The company has a debt-to-equity ratio of 0.11, a quick ratio of 5.06 and a current ratio of 5.06. SWK Holdings Co. has a 1 year low of $15.14 and a 1 year high of $18.49. The firm has a 50 day moving average price of $16.16 and a 200 day moving average price of $16.71.

About SWK

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.